In addition, FABP4 promoted aggressive acute myeloid leukemia (AML) in obesity by enhancing aberrant DNA methyltransferase 1 (DNMT1)-dependent DNA methylation of tumor cells [42]. The gene discussed is DNMT1; the disease is obesity due to melanocortin 4 receptor deficiency.